✦ LIBER ✦
The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause
✍ Scribed by Jacquie Chirgwin; Zhuoxin Sun; Ian Smith; Karen N. Price; Beat Thürlimann; Bent Ejlertsen; Hervé Bonnefoi; Meredith M. Regan; Aron Goldhirsch; Alan S. Coates; for the BIG 1-98 Collaborative and International Breast Cancer Study Groups
- Publisher
- Springer US
- Year
- 2011
- Tongue
- English
- Weight
- 317 KB
- Volume
- 131
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.